← Eichor
Study identifier: NCT06367309 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

ExtrAperitoneaL Plasty vs Intraperitoneal oNlay mEsh in Ventral Hernia Repair

Condition: Ventral Hernia · Abdominal Wall Defect  ·  Sponsor: University Hospital, Basel, Switzerland

PhaseNA
Planned participants138
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study investigates on the effect of two different operative techniques to treat abdominal wall hernias. The goal of this clinical trial is to learn if the eTEP (Extended totally extraperitoneal repair) technique leads to a better outcome than the IPOM (Intraperitoneal onlay mesh) technique. The main questions it aims to answer are: * pain after the operation * rate of complications * rate of recurrence and reoperations * quality of life. Participants will: Either be operated using the eTEP or the IPOM technique. Be followed up either in person or via email / phone call at day 1, day 7, day 14, 6 weeks, 6 months, 1, 3 and 5 years after the surgery to asses the above-stated main and some more outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Fiorenzo Angehrn, MD  ·  0041 61 777 73 17  ·  fiorenzo.angehrn@clarunis.ch

Always discuss trial participation with your own doctor first.

Locations (1)

St. Clara HospitalBasel, Canton of Basel-City, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06367309